{{Rsnum
|rsid=1065779
|Gene=CYP19A1
|Chromosome=15
|position=51212614
|Orientation=minus
|GMAF=0.4146
|Gene_s=CYP19A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 33.6 | 47.8 | 18.6
| HCB | 26.5 | 52.9 | 20.6
| JPT | 23.4 | 49.5 | 27.0
| YRI | 2.1 | 32.9 | 65.1
| ASW | 7.0 | 29.8 | 63.2
| CHB | 26.5 | 52.9 | 20.6
| CHD | 27.1 | 51.4 | 21.5
| GIH | 13.9 | 49.5 | 36.6
| LWK | 3.6 | 39.1 | 57.3
| MEX | 12.1 | 50.0 | 37.9
| MKK | 15.6 | 50.6 | 33.8
| TSI | 25.7 | 44.6 | 29.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24324964
|Title=CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer
|OA=1
}}

{{PMID Auto
|PMID=17507620
|Title=Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
}}

{{PMID Auto
|PMID=17827443
|Title=Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.
|OA=1
}}

{{PMID Auto
|PMID=19168589
|Title=Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China.
|OA=1
}}

{{on chip | Illumina Human 1M}}